Fetal Tissue Transplantation
Am J Dis Child 143:149, Nadler,H.L., 1989
Multicenter Study of Autologous Adrenal Medullary Transplantation to Corpus Striatum in Pts with Advanced Parkinson's Dis
NEJM 320:337-341, Goetz,C.G.,et al, 1989
Autopsy Findings in a Patient Who Had an Adrenal-To-Brain Transplant for Parkinson's Disease
Neurol 39:235-238, Peterson,D.I.,et al, 1989
MR Imaging of Parkinson Disease with Spin-Echo and Gradient-Echo Sequences
AJR 152:159-165, Braffman,B.H.,et al, 1989
A Double-Blind Crossover Comparison of Sinemet CR4 and Standard Sinemet 25/100 in Patients with Parkinson's Disease
JNNP 52:207-212, Cedarbaum,J.M.,et al, 1989
Efficacy of Sinemet CR4 in Subgroups of Patients with Parkinson's Disease
JNNP 52:83-88, Factor,S.A.,et al, 1989
Frozen Shoulder and Other Shoulder Disturbances in Parkinson's Disease
JNNP 52:63-66, Riley,D.,et al, 1989
Primary Progressive Cerebellar Ataxia
Neuroradiology 31:16-18, Bradac,G.B.,et al, 1989
Neurofibromatosis Type 1 (Recklinghausen's Disease) , Neurologic and Cognitive Assessment
Am J Dis Child 143:833-837, Eldridge,R.,et al, 1989
Hemiballism-Hemichorea, Clinical and Pharmacologic Findings in 21 Patients
Arch Neurol 46:862-867, Dewey,R.B.&Jankovic,J., 1989
Emotionalism after Stroke
BMJ 298:991-994, House,A.,et al, 1989
Sleep Abnormalities in Progressive Supranuclear Palsy
Ann Neurol 25:577-581, Aldrich,M.S.,et al, 1989
Autologous Adrenal Medullary Transplant in Progressive Supranuclear Palsy
Neurol 39:1066-1068, Koller,W.C.,et al, 1989
MR Imaging in Progressive Suupranuclear Palsy and Shy-Drager Syndrome
J Comput Assist Tomogr 13:555-560, Savoiardo,M.,et al, 1989
Diltiazem-Induced Parkinsonism
Am J Med 87:95-96, Dick,R.S.&Barold,S.S., 1989
Apraxia in Alzheimer's Disease
Neurol 39:664-668, Rapcsak,S.Z.,et al, 1989
Risk Factors for Recurrent Nonsyncopal Falls, A Prospective Study
JAMA 261:2663-2668, Nevitt,M.C.,et al, 1989
Implantation of Tissue Into the Brain, An Immunologic Perspective
JAMA 261:2674-2676, Gill,T.J.&Lund,R.D., 1989
Apraxia of Eyelid Opening Secondary to Right Hemisphere Infarction
Ann Neurol 25:622-624, Kohnston,J.C.,et al, 1989
Pergolide and Selegiline for Parkinson's Disease
The Medical Letter, 31:81-841989., , 1989
Continuous Levodopa Infusions to Treat Complex Dystonia in Parkinson's Disease
Neurol 39:888-891, Sage,J.I.,et al, 1989
Dopa Responsive Dystonia:A Treatable Condition Misdiagnosed as Cerebral Palsy
BMJ 298:1019-1020, Boyd,K.&Patterson,V., 1989
Cognitive Impairments Associated with Early Parkinson's Disease
Neurol 39:557-561, Levin,B.E.,et al, 1989
Clinical and Pathological Aspects of Parkinsonism in Alzheimer's Disease, A Role for Extranigral Factors?
Arch Neurol 46:651-657, Morris,J.C.,et al, 1989
Neuropathological Distinction Between Parkinson's Dementia and Parkinson's Plus Alzheimer's Disease
Ann Neurol 26:309-320, delaMonte,S.M.,et al, 1989
Environmental Factors and Parkinson's Disease:A Case-Control Study in China
Neurol 39:660-664, Tanner,C.M.,et al, 1989
Long-Term Efficacy and Safety of Deprenyl (Selegiline) in Advanced Parkinson's Disease
Neurol 39:1109-1111, Golbe,L.I.,et al, 1989
The Effect of Deprenyl (Selegiline) on the Natural History of Parkinson's Disease
Science 245:519-522, Tetrud,J.W.&Langston,W., 1989
Agonist Substitution in Advanced Parkinson's Disease
Neurol 39:1121-1122, Goetz,C.G.,et al, 1989
Physiology & Pharmacology of Dopamine D2-Receptors:Their Implications in Dopamine-Substitute Therapy for Park
Neurol 39:1106-1108, Mercuri,N.B.,et al, 1989
Human Fetal Dopamine Neurons Grafted Into the Striatum in Two Patients with Severe Parkinson's 6-Mo Follow-up
Arch Neurol 46:615-631, Lindvall,O.,et al, 1989
The Ethical Use of Human Fetal Tissue in Medicine
NEJM 320:1093-1096, Greely,H.T.,et al, 1989
The Politics of Transplantation of Human Fetal Tissue
NEJM 320:1079-1082, Annas,G.J.&Elias,S., 1989
Postmortem Analysis of Adrenal-Medulla-to-Caudate Autograft in a Patient with Parkinson's Disease
Ann Neurol 25:607-614, Hurtig,H.,et al, 1989
Adrenal Medullary Transplantation to the Caudate Nucleus in Parkinson's Disease, Initial Results in 18 Patients
Arch Neurol 46:487-491, Allen,G.S.,et al, 1989
Adrenal Medullary Autografts in Patients with Parkinson's Disease
NEJM 321:324-327, Tanner,C.M.,et al, 1989
Clinical, Biochem, & Neuropath of Transplantation of Adrenal Medulla to Caudate Nucleus for Parkinson's
Neurol 39:1227-1234, Jankovic,J.,et al, 1989
Amount and Distribution of Dietary Protein Affects Clinical Response to Levodopa in Parkinson's Disease
Neurol 39:552-556, Carter,J.H., 1989
Influence of Fluctuations of Plasma Large Neutral Amino Acids with Normal Diets on the Clinical Response to Levodopa
JNNP 52:481-487, Nutt,J.G.,et al, 1989
The Effect of Dietary Protein on the Efficacy of L-Dopa:A Double-Blind Study
Neurol 39:549-552, Tsui,J.K.,et al, 1989
Accuracy of Self-Reported Disability in Patients with Parkinsonism
Arch Neurol 46:955-959, Brown,R.G.,et al, 1989
Psychiatric Aspects of Parkinson's Disease, Dementia, Depression, and Rarely Psychosis
BMJ 299:3-4, Baldwin,R.C.&Byrne,E.J., 1989
Effect of Age at Onset on Progression and Mortality in Parkinson's Disease
Neurol 39:1187-1190, Diamond,S.G.,et al, 1989
Diffuse Lewy Body Disease:Clinical Features in 15 Cases
JNNP 52:709-717, Byrne,E.J., 1989
The Efficacy of (+) -4-Propyl-9-Hydroxynaphthoxazine as Adjunctive Therapy in Parkinson's Disease
JNNP 52:732-735, Weiner,W.J.,et al, 1989
Diffuse Lewy Body Disease and Progressive Dementia
Neurol 38:1520-1528, Burkhardt,C.R.,et al, 1988
Hand Contractures in Parkinson's Disease
JNNP 51:1221-1223, Kyriakides,T.&Hewer,R.L., 1988
PHNO[ (+) -4-Propyl-9-Hydroxynaphthoxazine]:A New and Effective Anti-Parkinson's Disease Agent
Neurol 38:1541-1545, Muenter,M.D.,et al, 1988
Risk Factors for Progression in Parkinson's Disease
Neurol 38:1841-1844, Goetz,C.G.,et al, 1988
Role of Subcutaneous Apomorphine in Parkinsonian Voiding Dysfunction
Lancet 2:1451-1453, Christmas,T.J.,et al, 1988